Novo Nordisk, Eli Lilly rake in cash from weight-loss drugs
Washington Post
Novo Nordisk and Eli Lilly reported booming sales from their blockbuster diabetes and weight-loss drugs as both race to keep up with consumer demand.
https://www.washingtonpost.com/business/2023/11/02/weight-loss-earnings-eli-lilly-novo-nordisk/